3[1]Singh O, Rao L V, Gaur A et al. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines including antibodies against human chorionic gonadotropin[J]. Fertil Steril,1989; 52: 739
4[2]Pal R, Singh O, Rao L V et al. Bioneutralization capacity of the antibodies generated in woman by the beta subunit of human chorionic gonadotrophin(βhCG) and βhCG associated with alpha subunit of ovine luteinizing hormone linked to carriers[J]. Am J Reprod Immunol,1990;22:124
5[3]Talwar G P, Singh O, Pal R et al.A vaccine that prevents pregnancy in women[J]. Proc Natl Acad Sci USA, 1994;91:8532
6[4]Rock E P, Czaplicki J, Milan A. Structural analysis of the car-boxyl terminal peptide from human chorionic gonadotropin β subunit by two dimensional nuclear magnetic resonance spectroscopy[J]. Am J Reprod Immunol, 1996;35:156
7[5]Castle P E, Dean J. Molecular genetics of the zona pellucida: implications for immunocontraceptive strategies[J] .J Reprod Fertil, 1996;50:1
8[6]Diekman A B, Herr J C. Sperm antigens and their use in the development of an immunocontraceptive[J]. Am J Reprod Immunol, 1997;37:111
9[7]Herr J C. Update on the center for recombinant gamete contraceptive vaccinogens[ J]. Am J Reprod Immunol, 1996; 35:184
10[8]Stevens V C. Progress in the development of human chorionic gonadotropin antifertility vaccines[J]. Am J Reprod Immunol, 1996;35:148
